- Headquarters
- Bhopal, Karnataka
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- strainx.in
- Total Funding
- $33.6M
- Last Round
- $6.3M SeedJun 2026
- Rounds
- 4
About
StrainX Bioworks uses synthetic biology and precision fermentation to produce high-value alternative proteins and biomolecules for food, nutraceuticals, and beauty industries. Founded by IIT Delhi alumni, the company engineers custom microbial strains and operates a 10,000-litre fermentation facility in Bhopal, India.
Summary
StraiNX Bioworks is a Biotech company based in Bhopal, United States, founded in 2023. It has raised $33.6M in total across 4 rounds, most recently a $6.3M Seed round in Jun 2026. Investors include Prime Venture Partners, Leo Capital and Wing VC.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.